Ritesh International expands capacity by 50% with ₹7 crore capex

1 min read     Updated on 17 Aug 2026, 12:55 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Ritesh International Limited is expanding its Ahmedgarh manufacturing facility by 50%, raising daily output from 80 to 120 metric tons. The ₹7 crore investment is primarily funded by internal accruals (₹6 crore) with minimal bank debt (₹1 crore). Commercial production is targeted for Q1 FY27-28, aiming to capitalize on high utilization rates and growing demand for stearic acid and related products.

powered bylight_fuzz_icon
48497107

*this image is generated using AI for illustrative purposes only.

Ritesh International has approved a 50% expansion of its manufacturing capacity at its Ahmedgarh facility to address rising demand for stearic acid, fatty acid, and glycerin. The company plans to increase its daily production capability from 80 metric tons to 120 metric tons, with commercial operations expected to begin in Q1 FY27-28.

The expansion involves a total capital expenditure of ₹7 crore. Financing will be structured through a mix of long-term bank loans amounting to approximately ₹1 crore and internal accruals covering the balance of ₹6 crore. The project is scheduled for completion within approximately eight months.

Strategic Implications

Ritesh Arora, Chairman and Managing Director, stated that existing facilities are operating near peak capacity utilization. The expansion aims to strengthen market share and enhance operating margins by meeting surging customer demand across core markets. The company emphasized that leveraging debt financing alongside internal accruals allows it to maintain a healthy balance sheet while positioning for sustained revenue growth.

What the Numbers Show

The funding structure reveals a strong reliance on internal resources, with internal accruals accounting for approximately 86% of the total ₹7 crore capital expenditure. This suggests limited incremental leverage pressure on the balance sheet, as only ₹1 crore is being raised through external long-term bank debt. This capital-light approach to expansion indicates the company’s current cash generation capabilities are sufficient to support significant capacity additions without heavily diluting equity or increasing interest burden proportionately.

Project Metric Details
Capacity Increase 50% (from 80 to 120 metric tons/day)
Total Capex ₹7 crore
Funding Source ₹6 crore internal accruals, ₹1 crore bank debt
Timeline Approx. 8 months
Commercial Start Q1 FY27-28

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Rijul Arora, CFO and Wholetime Director, signed the intimation on August 17, 2026.

Historical Stock Returns for Ritesh International

1 Day5 Days1 Month6 Months1 Year5 Years
+4.25%-0.60%+23.81%+28.33%+172.73%+157.43%

How will the 50% capacity expansion impact Ritesh International's operating margins given the current pricing trends for stearic acid and glycerin in FY27-28?

What is the company's strategy to maintain its near-peak capacity utilization rates once the new 120 metric tons/day production capability comes online?

Could the reliance on internal accruals for 86% of the capex limit Ritesh International's ability to pursue larger strategic acquisitions or diversification projects in the near term?

Ritesh International Q1FY27 net profit surges 366% on revenue growth

2 min read     Updated on 27 Jul 2026, 11:22 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Ritesh International reported a 366% YoY jump in Q1FY27 net profit to ₹174.40 lakh, supported by 44.2% revenue growth. Improved operating leverage and controlled costs drove the margin expansion.

powered bylight_fuzz_icon
46698319

*this image is generated using AI for illustrative purposes only.

Ritesh International reported a sharp acceleration in profitability for the first quarter of FY27 (ended June 30, 2026), with net profit from continuing operations surging 366% year-on-year to ₹174.40 lakh. The gain was underpinned by a robust 44.2% rise in revenue from operations, which reached ₹5,054.00 lakh compared to ₹3,504.73 lakh in the same period last year. This performance marks a significant improvement over the previous quarter (Q4FY26), where net profit stood at ₹105.12 lakh, signaling strong operational momentum for the non-edible oils manufacturer.

The Board of Directors approved the unaudited financial results during a meeting held on July 27, 2026. The figures were reviewed by M/s Ashok Shashi & Co., the statutory auditor of the company, in accordance with Standard on Review Engagements (SRE) 2410. The audit committee also reviewed the results prior to board approval. The filing confirms compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Overview

Revenue growth was the primary driver for the quarter, expanding by ₹1,549.27 lakh year-on-year. While total expenses increased to ₹4,819.86 lakh from ₹3,449.59 lakh in Q1FY26, the cost structure improved relative to top-line growth. Cost of materials consumed rose to ₹3,934.80 lakh, reflecting higher operational volume. Employee benefits expense saw a modest increase to ₹121.50 lakh, while finance costs remained contained at ₹24.62 lakh. Other income contributed minimally at ₹2.06 lakh, indicating that the profit surge was driven entirely by core operational performance rather than one-off gains.

Metric Q1FY27 (₹ Lakh) Q1FY26 (₹ Lakh) Change (%)
Revenue from Operations 5,054.00 3,504.73 +44.2%
Total Expenses 4,819.86 3,449.59 +39.7%
Profit Before Tax 234.40 47.55 +392.9%
Net Profit 174.40 37.55 +364.4%
EPS (Basic) ₹1.86 ₹0.44 +322.7%

What the Numbers Show

The divergence between revenue growth (44.2%) and expense growth (39.7%) highlights improved operating leverage for Ritesh International in Q1FY27. This operational efficiency translated directly into the bottom line, with profit before tax jumping nearly fourfold. Notably, other income contributed minimally at ₹2.06 lakh, indicating that the profit surge was driven entirely by core operational performance rather than one-off gains. The company operates in a single reportable segment, Non-edible Oils, suggesting this sector-wide strength is concentrated within its primary business line. Earnings per share (EPS) more than quadrupled to ₹1.86, signaling enhanced value creation for shareholders despite the inflationary pressure on material costs.

Historical Stock Returns for Ritesh International

1 Day5 Days1 Month6 Months1 Year5 Years
+4.25%-0.60%+23.81%+28.33%+172.73%+157.43%

Can Ritesh International sustain its improved operating leverage and margin expansion in Q2FY27 given the persistent inflationary pressure on raw material costs?

How will the company allocate the increased cash flows from this profitability surge—will it prioritize debt reduction, capacity expansion, or shareholder returns?

What specific strategic initiatives or market share gains drove the 44.2% revenue growth, and are these trends likely to continue in the non-edible oils sector?

More News on Ritesh International

1 Year Returns:+172.73%